While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows. The post Balancing Innovation and Risk in Healthtech appeared first on MedCity News.
Experian Health is very pleased to announce that we’ve ranked #1 in the 2025 Best in KLAS: Software & Services report, for our Contract Manager and Contract Analysis product, for the third consecutive year. Contract Manager, when paired with Contract Analysis, empowers healthcare providers by ensuring payers comply with contract terms, identifying and recovering underpayments, and arming them…
[Sponsored] In an interview, Redox CEO Trip Hofer shared why the company is well-positioned to facilitate the push for the nationwide exchange of electronic health information facilitated by the TEFCA framework. The post How Redox is Future-Proofing Healthcare Data as Interoperability Standards Evolve appeared first on MedCity News.
Abortion foes worried before his election that President Donald Trump had moved on, now that Roe v. Wade is overturned and abortion policy, as he said on the campaign trail, “has been returned to the states.” Their concerns mounted after Trump named Robert F. Kennedy Jr., a longtime supporter of abortion rights, to lead the…
SUITLAND, Md. — At a SuperSuds Laundromat just south of Washington, D.C., a steady stream of customers loaded clothes into washers and dryers on a recent Sunday morning, passing the time on their phones or watching television. Amid the low hum of spinning clothes, Adrienne Jones made the rounds in a bright yellow sweatshirt, asking…
Expert notes that insurance coverage remains poor for obesity as a medical condition
Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine to manage “off” periods experienced by Parkinson’s disease patients. Approval of Onapgo comes after the FDA twice turned back applications for the drug/device combination product. The post Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval appeared first on MedCity News.
Amid renewed interest in Medicaid work requirements as part of a broader legislative package designed to significantly reduce federal Medicaid spending, KFF has updated its analysis of the work status and demographic characteristics of Medicaid enrollees with the latest data. Data show that, in 2023, 92% of Medicaid adults were either working full or part-time…
These figures provide a general overview of U.S. funding for global health.
“It’s kind of like having a big brother in a box, so to speak,” EMS director says